drugset / Trial / NCT01730339

Safety and Efficacy Study of PF-06473871 to Reduce Hypertrophic Scars From Recurring Post-Revision Surgery

NCT01730339 ↗

Phase 2 Completed 103 enrolled Pfizer
RandomizedDouble-blindTreatment

Summary

The study will compare how well PF-06473871 works versus placebo in reducing skin scarring after scar revision surgery of existing breast scars. The study will also evaluate the safety of PF-06473871 in healthy adult subjects.

Timeline

Start
2012-12
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator PF-06473871 Unknown — Other

Indications